Robert G. Savage, Director at EPICEPT CORP (EPCT), bought 28,600 shares at $1.61 ($46K) on 2007-08-21, disclosed to the SEC on 2007-08-22.
Open-market purchase of $46k EPCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.56 | 3,000 | $5K | 10.3% |
| 2 | $1.58 | 7,000 | $11K | 24.3% |
| 3 | $1.59 | 3,000 | $5K | 10.5% |
| 4 | $1.60 | 3,000 | $5K | 10.5% |
| 5 | $1.61 | 2,300 | $4K | 8.1% |
| 6 | $1.61 | 2,000 |
| $3K |
| 7.1% |
| 7 | $1.61 | 6,100 | $10K | 21.5% |
| 8 | $1.61 | 2,200 | $4K | 7.8% |
| Total | $1.59 avg | 28,600 | $46K | 100% |
| Filing → |
| EPCT | BUY | 2007-08-20 | $6K | — | Filing → |